Please login to the form below

Not currently logged in
Email:
Password:

Lucid wins Queen’s Award for business success

Accolade comes shortly after the agency celebrated its ten-year anniversary

The Queen's AwardLucid Group has received a Queen’s Award for Enterprise in International Trade, with the accolade arriving shortly after the Buckinghamshire, UK-based agency celebrated its ten-year anniversary.

The prestigious trade award can only go to firms that manage to avoid any ‘slumps’ or ‘dips’ over three ‘outstanding’ years or six ‘continuous’ years.

Jan Steele, Lucid’s Co-founder and COO, said: “Winning a Queen’s Award for Enterprise is a tremendous honour for everyone who has contributed to our success.

“Our shared passion and vision to improve patient outcomes via behaviour change and strategic communication programmes is unrelenting and is the key to our winning formula.

“To be granted such a prestigious award in a category where were competing with very diverse businesses makes us very proud.”

Lucid’s strategy sees its operations split into two divisions, with a US office pulling in 66% of its oversees sales and a UK base that covers the rest of the world.

The firm's Queen’s Award is the latest in a line of prizes for the agency that include Medical Education Consultancy of the year at Communiqué’s 2015 awards - the third consecutive year of winning that prize - and Support Agency of the Year at last year’s PMEA.

Article by
Gemma Jones

26th April 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics